BIOT
Biotech Acquisition Company Class A Ordinary Shares
BIOT
BIOT
Delisted
BIOT was delisted on the 2nd of February, 2023.
68 hedge funds and large institutions have $226M invested in Biotech Acquisition Company Class A Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 11 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
27% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 11
Holders
68
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$3.79M | |
| 2 | +$2.01M | |
| 3 | +$1.16M | |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$800K |
| 5 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
+$562K |
Top Sellers
| 1 | -$7.93M | |
| 2 | -$2.04M | |
| 3 | -$1.91M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.44M |
| 5 |
JP Morgan Chase
New York
|
-$1M |